Ankyrin-linked hereditary spherocytosis in an African-American kindred

American Journal of Hematology

Volumn 83, Issue 10, 2008, Pages 789-794

  Sangerman, Jose ^a   Maksimova, Yelena ^a   Edelman, E Jennifer ^a   Morrow, Jon S ^a   Forget, Bernard G ^a   Gallagher, Patrick G ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANKYRIN; ANKYRIN 1; COMPLEMENTARY DNA; GENOMIC DNA; ISOPROTEIN; METHIONINE; UNCLASSIFIED DRUG;

AFRICAN AMERICAN; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ERYTHROCYTE MEMBRANE; ERYTHROID CELL; EXON; GENE LOCATION; GENE MUTATION; GENE SEQUENCE; GENETIC SCREENING; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HEREDITARY SPHEROCYTOSIS; HETEROZYGOSITY; HUMAN; HUMAN CELL; MUTATIONAL ANALYSIS; NONHUMAN; NULL ALLELE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; RABBIT; RETICULOCYTE LYSATE; RNA TRANSLATION; START CODON; TRANSLATION INITIATION;

AFRICAN AMERICANS; ALLELES; ANKYRINS; BASE SEQUENCE; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CODON; DNA MUTATIONAL ANALYSIS; EXONS; FAMILY; FEMALE; GENE FREQUENCY; GENETIC SCREENING; HETEROZYGOTE; HUMANS; MALE; MOLECULAR SEQUENCE DATA; MUTATION; PEDIGREE; SIBLINGS; SPHEROCYTOSIS, HEREDITARY;

EID: 53549099397     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21254     Document Type: Article

References (63)

1. Eber S, Lux SE. Hereditary spherocytosis - Defects in proteins that connect the membrane skeleton to the lipid bilayer. Semin Hematol 2004;41:118-141.
2. Bennett V, Healy J. Organizing the fluid membrane bilayer: Diseases linked to spectrin and ankyrin. Trends Mol Med 2008;14:28-36.
3. Lanciotti M, Perutelli P, Valetto A, et al. Ankyrin deficiency is the most common defect in dominant and non dominant hereditary spherocytosis. Haematologica 1997;82:460-462.
4. Lee YK, Cho HI, Park SS, et al. Abnormalities of erythrocyte membrane proteins in Korean patients with hereditary spherocytosis. J Korean Med Sci 2000;15:284-288.
5. Miraglia del Giudice E, Iolascon A, Pinto L, et al. Erythrocyte membrane protein alterations underlying clinical heterogeneity in hereditary spherocytosis. Br J Haematol 1994;88:52-55.
6. Pekrun A, Eber SW, Kuhlmey A, et al. Combined ankyrin and spectrin deficiency in hereditary spherocytosis. Ann Hematol 1993;67:89-93.
7. Premetis E, Stamoulakatou A, Loukopoulos D. Erythropoiesis: Hereditary spherocytosis in Greece - Collective data on a large number of patients. Hematology 1999;4:361-366.
8. Ricard MP, Gilsanz F, Millan I. Erythroid membrane protein defects in hereditary spherocytosis. A study of 62 Spanish cases. Haematologica 2000;85:994-995.
9. Saad ST, Costa FF, Vicentim DL, et al. Red cell membrane protein abnormalities in hereditary spherocytosis in Brazil. Br J Haematol 1994;88:295-299.
10. Savvides P, Shalev O, John KM, et al. Combined spectrin and ankyrin deficiency is common in autosomal dominant hereditary spherocytosis. Blood 1993;82:2953-2960.
11. Boguslawska DM, Heger E, Chorzalska A, et al. Hereditary spherocytosis: Identification of several HS families with ankyrin and band 3 deficiency in a population of southwestern Poland. Ann Hematol 2004;83:28-33.
12. Rocha S, Rebelo I, Costa E, et al. Protein deficiency balance as a predictor of clinical outcome in hereditary spherocytosis. Eur J Haematol 2005;74:374-380.
13. Sanchez-Lopez JY, Camacho AL, Magana MT, et al. Red cell membrane protein deficiencies in Mexican patients with hereditary spherocytosis. Blood Cells Mol Dis 2003;31:357-359.
14. Bennett V. Immunoreactive forms of human erythrocyte ankyrin are present in diverse cells and tissues. Nature 1979;281:597-599.
15. Luna EJ, Kidd GH, Branton D. Identification by peptide analysis of the spectrin-binding protein in human erythrocytes. J Biol Chem 1979;254:2526-2532.
16. Peters LL, Lux SE. Ankyrins: Structure and function in normal cells and hereditary spherocytes. Semin Hematol 1993;30:85-118.
17. Birkenmeier CS, Sharp JJ, Gifford EJ, et al. An alternative first exon in the distal end of the erythroid ankyrin gene leads to production of a small isoform containing an NH2-terminal membrane anchor. Genomics 1998;50:79-88.
18. Birkenmeier CS, White RA, Peters LL, et al. Complex patterns of sequence variation and multiple 5′ and 3′ ends are found among transcripts of the erythroid ankyrin gene. J Biol Chem 1993;268:9533-9540.
19. Doctor RB, Chen J, Peters LL, et al. Distribution of epithelial ankyrin (Ank3) spliceoforms in renal proximal and distal tubules. Am J Physiol 1998;74; F129-F138.
20. Gallagher PG, Forget BG. An alternate promoter directs expression of a truncated, muscle-specific isoform of the human ankyrin 1 gene. J Biol Chem 1998;273:1339-1348.
21. Kordeli E, Bennett V. Distinct ankyrin isoforms at neuron cell bodies and nodes of Ranvier resolved using erythrocyte ankyrin-deficient mice. J Cell Biol 1991;114:1243-1258.
22. Kordeli E, Davis J, Trapp B, et al. An isoform of ankyrin is localized at nodes of ranvier in myelinated axons of central and peripheral nerves. J Cell Biol 1990;110:1341-1352.
23. Kordeli E, Lambert S, Bennett V. AnkyrinG. A new ankyrin gene with neural-specific isoforms localized at the axonal initial segment and node of ranvier. J Biol Chem 1995;270:2352-2359.
24. Lambert S, Yu H, Prchal JT, et al. cDNA sequence for human erythrocyte ankyrin. Proc Natl Acad Sci USA 1990;87:1730-1734.
25. Lux SE, John KM, Bennett V. Analysis of cDNA for human erythrocyte ankyrin indicates a repeated structure with homology to tissue-differentiation and cell-cycle control proteins. Nature 1990;344:36-42.
26. Otto E, Kunimoto M, McLaughlin T, Bennett V. Isolation and characterization of cDNAs encoding human brain ankyrins reveal a family of alternatively spliced genes. J Cell Biol 1991;114:241-253.
27. Peters B, Kaiser HW, Magin TM. Skin-specific expression of ank-3(93), a novel ankyrin-3 splice variant. J Invest Dermatol 2001;16:216-223.
28. Peters LL, John KM, Lu FM, et al. Ank3 (epithelial ankyrin), a widely distributed new member of the ankyrin gene family and the major ankyrin in kidney, is expressed in alternatively spliced forms, including forms that lack the repeat domain. J Cell Biol 1995;130:313-330.
29. Thevananther S, Kolli AH, Devarajan P. Identification of a novel ankyrin isoform (AnkG190) in kidney and lung that associates with the plasma membrane and binds alpha-Na, K-ATPase. J Biol Chem 1998;273:23952-23958.
30. Eber SW, Gonzalez JM, Lux ML, et al. Ankyrin-1 mutations are a major cause of dominant and recessive hereditary spherocytosis. Nat Genet 1996;13:214-218.
31. Gallagher PG. Hematologically important mutations: Ankyrin variants in hereditary spherocytosis. Blood Cells Mol Dis 2005;35:345-347.
32. Gallagher PG, Tse WT, Scarpa AL, et al. Structure and organization of the human ankyrin-1 gene. Basis for complexity of pre-mRNA processing. J Biol Chem 1997;272:19920-19928.
33. Ozcan R, Jarolim P, Lux SE, et al. Simultaneous (AC)n microsatellite polymorphism analysis and single-stranded conformation polymorphism screening is an efficient strategy for detecting ankyrin-1 mutations in dominant hereditary spherocytosis. Br J Haematol 2003;122:669-677.
34. Edelman EJ, Maksimova Y, Duru F, et al. A complex splicing defect associated with homozygous ankyrin-deficient hereditary spherocytosis. Blood 2007;109:5491-5493.
35. Yawata Y, Kanzaki A, Yawata S, et al. Characteristic features of the genotype and phenotype of hereditary spherocytosis in the Japanese population. Int J Hematol 2000;71:118-135.
36. Leite RC, Besseres DS, Ferreira JS, et al. Low frequency of ankyrin mutations in hereditary spherocytosis: Identification of three novel mutations. Hum Mutat 2000;16:529-534.
37. Zerhouni F, Guetarni D, Henni T, et al. Occurrence and characteristics of hereditary spherocytosis in Algeria. Eur J Haematol 1991;47:42-47.
38. Ustun C, Kutlar F, Holley L, et al. Interaction of sickle cell trait with hereditary spherocytosis: Splenic infarcts and sequestration. Acta Haematol 2003;109:46-49.
39. Peabody DS. Translation initiation at non-AUG triplets in mammalian cells. J Biol Chem 1989;264:5031-5035.
40. Drabkin HJ, RajBhandary UL. Initiation of protein synthesis in mammalian cells with codons other than AUG and amino acids other than methionine. Mol Cell Biol 1998;18:5140-5147.
41. Stoner MA, Auerbach SS, Zamule SM, et al. Transactivation of a DR-1 PPRE by a human constitutive androstane receptor variant expressed from internal protein translation start sites. Nucleic Acids Res 2007;35:2177-2190.
42. Kozak M. Some thoughts about translational regulation: Forward and backward glances. J Cell Biochem 2007;102:280-290.
43. Sonenberg N, Hinnebusch AG. New modes of translational control in development, behavior, and disease. Mol Cell 2007;28:721-729.
44. Mitchell G, Brody LC, Looney J, et al. An initiator codon mutation in ornithine-delta aminotransferase causing gyrate atrophy of the choroid and retina. J Clin Invest 1988;81:630-633.
45. Patten JL, Johns DR, Valle D, et al. Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright's hereditary osteodystrophy. N Engl J Med 1990;322:1412-1419.
46. Gupta A, Hattori Y, Agarwal S. Initiation codon mutation in an Asian Indian family. Am J Hematol 2002;71:134-136.
47. Quinteiro C, Castro-Feijoo L, Loidi L, et al. Novel mutation involving the translation initiation codon of the growth hormone receptor gene (GHR) in a patient with Laron syndrome. J Pediatr Endocrinol Metab 2002;15:1041-1045.
48. Zoppi S, Wilson CM, Harbison MD, et al. Complete testicular feminization caused by an amino-terminal truncation of the androgen receptor with downstream initiation. J Clin Invest 1993;9:1105-1112.
49. O'Neill GN, Aoki M, Brown RH Jr, et al. ABCD1 translation-initiator mutation demonstrates genotype-phenotype correlation for AMN. Neurology 2001;57:1956-1962.
50. Nguyen M, He B, Karaplis A. Nuclear forms of parathyroid hormone-related peptide are translated from non-AUG start sites downstream from the initiator methionine. Endocrinology 2001;142:694-703.
51. Lilleberg SL. In-depth mutation and SNP discovery using DHPLC gene scanning. Curr Opin Drug Discov Devel 2003;6:237-252.
52. Yu B, Sawyer NA, Chiu C, et al. DNA mutation detection using denaturing high-performance liquid chromatography (DHPLC). Curr Protoc Hum Genet 2006;Chapter 7:Unit 7.10.
53. Bennett RR, den Dunnen J, O'Brien KF, et al. Detection of mutations in the dystrophin gene via automated DHPLC screening and direct sequencing. BMC Genet 2001;2:17.
54. Biggin A, Holman K, Brett M, et al. Detection of thirty novel FBN1 mutations in patients with Marfan syndrome or a related fibrillinopathy. Hum Mutat 2004;23:99.
55. Dahl F, Stenberg J, Fredriksson S, et al. Multigene amplification and massively parallel sequencing for cancer mutation discovery. Proc Natl Acad Sci USA 2007;104:9387-9392.
56. Patil N, Berno AJ, Hinds DA, et al. Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21. Science 2001;294:1719-1723.
57. Chee M, Yang R, Hubbell E, et al. Accessing genetic information with high-density DNA arrays. Science 1996;274:610-614.
58. Margulies M, Egholm M, Altman WE, et al. Genome sequencing in microfabricated high-density picolitre reactors. Nature 2005;437:376-380.
59. Porreca GJ, Zhang K, Li JB. Multiplex amplification of large sets of human exons. Nat Methods 2007;4:931-936.
60. Fairbanks G, Steck TL, Wallach DF. Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane. Biochem 1971;10:2606-2617.
61. Marchesi SL, Nowles WJ, Morrow JS, et al. Abnormal spectrin in hereditary elliptocytosis. Blood 1986;67:141-151.
62. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685.
63. Kambouris M, Jackson CE, Feldman GL. Diagnosis of multiple endocrine neoplasia (MEN) 2A, 2B and familial medullary thyroid cancer (FMTC) by multiplex PCR and heteroduplex analyses of RET proto-oncogene mutations. Hum Mutat 1996;8:64-70.